Bifurcation Lesions Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: B858E340C70CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bifurcation Lesions Treatment in Global, including the following market information:

Global Bifurcation Lesions Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bifurcation Lesions Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

T Stent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bifurcation Lesions Treatment include Medtronic, Boston Scientific Corporation, Johnson& Johnson Services, Inc, Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation and Cardinal Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bifurcation Lesions Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bifurcation Lesions Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bifurcation Lesions Treatment Market Segment Percentages, by Type, 2021 (%)

• T Stent
• Culotte
• Crush
• V Stent
• Y Stent
• Jailed Balloon

Global Bifurcation Lesions Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bifurcation Lesions Treatment Market Segment Percentages, by Application, 2021 (%)

• Coronary Vascular
• Peripheral Vascular

Global Bifurcation Lesions Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bifurcation Lesions Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bifurcation Lesions Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bifurcation Lesions Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic
• Boston Scientific Corporation
• Johnson& Johnson Services, Inc
• Abbott
• C. R. Bard, Inc.
• Spectranetics
• Terumo Medical Corporation
• Cardinal Health

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bifurcation Lesions Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bifurcation Lesions Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIFURCATION LESIONS TREATMENT OVERALL MARKET SIZE

2.1 Global Bifurcation Lesions Treatment Market Size: 2021 VS 2028
2.2 Global Bifurcation Lesions Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bifurcation Lesions Treatment Players in Global Market
3.2 Top Global Bifurcation Lesions Treatment Companies Ranked by Revenue
3.3 Global Bifurcation Lesions Treatment Revenue by Companies
3.4 Top 3 and Top 5 Bifurcation Lesions Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bifurcation Lesions Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bifurcation Lesions Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Bifurcation Lesions Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bifurcation Lesions Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bifurcation Lesions Treatment Market Size Markets, 2021 & 2028
  4.1.2 T Stent
  4.1.3 Culotte
  4.1.4 Crush
  4.1.5 V Stent
  4.1.6 Y Stent
  4.1.7 Jailed Balloon
4.2 By Type - Global Bifurcation Lesions Treatment Revenue & Forecasts
  4.2.1 By Type - Global Bifurcation Lesions Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Bifurcation Lesions Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bifurcation Lesions Treatment Market Size, 2021 & 2028
  5.1.2 Coronary Vascular
  5.1.3 Peripheral Vascular
5.2 By Application - Global Bifurcation Lesions Treatment Revenue & Forecasts
  5.2.1 By Application - Global Bifurcation Lesions Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Bifurcation Lesions Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bifurcation Lesions Treatment Market Size, 2021 & 2028
6.2 By Region - Global Bifurcation Lesions Treatment Revenue & Forecasts
  6.2.1 By Region - Global Bifurcation Lesions Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Bifurcation Lesions Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bifurcation Lesions Treatment Revenue, 2017-2028
  6.3.2 US Bifurcation Lesions Treatment Market Size, 2017-2028
  6.3.3 Canada Bifurcation Lesions Treatment Market Size, 2017-2028
  6.3.4 Mexico Bifurcation Lesions Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bifurcation Lesions Treatment Revenue, 2017-2028
  6.4.2 Germany Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.3 France Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.4 U.K. Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.5 Italy Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.6 Russia Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Bifurcation Lesions Treatment Market Size, 2017-2028
  6.4.8 Benelux Bifurcation Lesions Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bifurcation Lesions Treatment Revenue, 2017-2028
  6.5.2 China Bifurcation Lesions Treatment Market Size, 2017-2028
  6.5.3 Japan Bifurcation Lesions Treatment Market Size, 2017-2028
  6.5.4 South Korea Bifurcation Lesions Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Bifurcation Lesions Treatment Market Size, 2017-2028
  6.5.6 India Bifurcation Lesions Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bifurcation Lesions Treatment Revenue, 2017-2028
  6.6.2 Brazil Bifurcation Lesions Treatment Market Size, 2017-2028
  6.6.3 Argentina Bifurcation Lesions Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bifurcation Lesions Treatment Revenue, 2017-2028
  6.7.2 Turkey Bifurcation Lesions Treatment Market Size, 2017-2028
  6.7.3 Israel Bifurcation Lesions Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Bifurcation Lesions Treatment Market Size, 2017-2028
  6.7.5 UAE Bifurcation Lesions Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Medtronic
  7.1.1 Medtronic Corporate Summary
  7.1.2 Medtronic Business Overview
  7.1.3 Medtronic Bifurcation Lesions Treatment Major Product Offerings
  7.1.4 Medtronic Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.1.5 Medtronic Key News
7.2 Boston Scientific Corporation
  7.2.1 Boston Scientific Corporation Corporate Summary
  7.2.2 Boston Scientific Corporation Business Overview
  7.2.3 Boston Scientific Corporation Bifurcation Lesions Treatment Major Product Offerings
  7.2.4 Boston Scientific Corporation Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.2.5 Boston Scientific Corporation Key News
7.3 Johnson& Johnson Services, Inc
  7.3.1 Johnson& Johnson Services, Inc Corporate Summary
  7.3.2 Johnson& Johnson Services, Inc Business Overview
  7.3.3 Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Major Product Offerings
  7.3.4 Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.3.5 Johnson& Johnson Services, Inc Key News
7.4 Abbott
  7.4.1 Abbott Corporate Summary
  7.4.2 Abbott Business Overview
  7.4.3 Abbott Bifurcation Lesions Treatment Major Product Offerings
  7.4.4 Abbott Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.4.5 Abbott Key News
7.5 C. R. Bard, Inc.
  7.5.1 C. R. Bard, Inc. Corporate Summary
  7.5.2 C. R. Bard, Inc. Business Overview
  7.5.3 C. R. Bard, Inc. Bifurcation Lesions Treatment Major Product Offerings
  7.5.4 C. R. Bard, Inc. Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.5.5 C. R. Bard, Inc. Key News
7.6 Spectranetics
  7.6.1 Spectranetics Corporate Summary
  7.6.2 Spectranetics Business Overview
  7.6.3 Spectranetics Bifurcation Lesions Treatment Major Product Offerings
  7.6.4 Spectranetics Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.6.5 Spectranetics Key News
7.7 Terumo Medical Corporation
  7.7.1 Terumo Medical Corporation Corporate Summary
  7.7.2 Terumo Medical Corporation Business Overview
  7.7.3 Terumo Medical Corporation Bifurcation Lesions Treatment Major Product Offerings
  7.7.4 Terumo Medical Corporation Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.7.5 Terumo Medical Corporation Key News
7.8 Cardinal Health
  7.8.1 Cardinal Health Corporate Summary
  7.8.2 Cardinal Health Business Overview
  7.8.3 Cardinal Health Bifurcation Lesions Treatment Major Product Offerings
  7.8.4 Cardinal Health Bifurcation Lesions Treatment Revenue in Global Market (2017-2022)
  7.8.5 Cardinal Health Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bifurcation Lesions Treatment Market Opportunities & Trends in Global Market
Table 2. Bifurcation Lesions Treatment Market Drivers in Global Market
Table 3. Bifurcation Lesions Treatment Market Restraints in Global Market
Table 4. Key Players of Bifurcation Lesions Treatment in Global Market
Table 5. Top Bifurcation Lesions Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bifurcation Lesions Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bifurcation Lesions Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bifurcation Lesions Treatment Product Type
Table 9. List of Global Tier 1 Bifurcation Lesions Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bifurcation Lesions Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bifurcation Lesions Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bifurcation Lesions Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bifurcation Lesions Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bifurcation Lesions Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bifurcation Lesions Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bifurcation Lesions Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bifurcation Lesions Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bifurcation Lesions Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bifurcation Lesions Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bifurcation Lesions Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bifurcation Lesions Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bifurcation Lesions Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bifurcation Lesions Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bifurcation Lesions Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Bifurcation Lesions Treatment Product Offerings
Table 32. Medtronic Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Boston Scientific Corporation Corporate Summary
Table 34. Boston Scientific Corporation Bifurcation Lesions Treatment Product Offerings
Table 35. Boston Scientific Corporation Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson& Johnson Services, Inc Corporate Summary
Table 37. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Product Offerings
Table 38. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Corporate Summary
Table 40. Abbott Bifurcation Lesions Treatment Product Offerings
Table 41. Abbott Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 42. C. R. Bard, Inc. Corporate Summary
Table 43. C. R. Bard, Inc. Bifurcation Lesions Treatment Product Offerings
Table 44. C. R. Bard, Inc. Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Spectranetics Corporate Summary
Table 46. Spectranetics Bifurcation Lesions Treatment Product Offerings
Table 47. Spectranetics Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Terumo Medical Corporation Corporate Summary
Table 49. Terumo Medical Corporation Bifurcation Lesions Treatment Product Offerings
Table 50. Terumo Medical Corporation Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Cardinal Health Corporate Summary
Table 52. Cardinal Health Bifurcation Lesions Treatment Product Offerings
Table 53. Cardinal Health Bifurcation Lesions Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bifurcation Lesions Treatment Segment by Type in 2021
Figure 2. Bifurcation Lesions Treatment Segment by Application in 2021
Figure 3. Global Bifurcation Lesions Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bifurcation Lesions Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bifurcation Lesions Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bifurcation Lesions Treatment Revenue in 2021
Figure 8. By Type - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 12. US Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 24. China Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bifurcation Lesions Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bifurcation Lesions Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Medtronic Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boston Scientific Corporation Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson& Johnson Services, Inc Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. C. R. Bard, Inc. Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Spectranetics Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Terumo Medical Corporation Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cardinal Health Bifurcation Lesions Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)